Market Place
Sourcing Support
All News #Library
Biotech
Allakos to be acquired by Concentra Bio for $0.33 in Cash per Share
02 Apr 2025 //
GLOBENEWSWIRE
Allakos axes program, lays off 75% of staff after phase 1 flop
28 Jan 2025 //
FIERCE BIOTECH
Allakos Reports Q3 2024 Financials & Provides Business Update
06 Nov 2024 //
GLOBENEWSWIRE
Allakos Announces Ph 1 Trial Results of Subcutaneous AK006
10 Oct 2024 //
GLOBENEWSWIRE
Allakos Provides Q2 2024 Financial Results And Business Update
07 Aug 2024 //
GLOBENEWSWIRE
Allakos Announces Phase 2 Lirentelimab Trials in Atopic Dermatitis
16 Jan 2024 //
PRESS RELEASE
Allakos Presents Data at EAACI Hybrid Congress 2023 Highlighting Lirentelimab
12 Jun 2023 //
GLOBENEWSWIRE
Allakos Announces Upcoming Presentation on Lirentelimab and AK006
05 Jun 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.